v3.26.3
Stock-Based Compensation (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Stock-Based Compensation [Abstract]    
Schedule of Stock-Based Compensation Expense

The following table presents stock-based compensation expense recognized in the accompanying condensed statements of operations:

 

    For the Three Months Ended
June 30,
 
    2026     2025  
             
Research and development   $ 27,452     $ 28,669  
General and administrative     33,794       20,256  
Total   $ 61,246     $ 48,925  

 

    For the Six Months Ended
June 30,
 
    2026     2025  
             
Research and development   $ 54,904     $ 69,066  
General and administrative     52,521       33,632  
Total   $ 107,425     $ 102,698  

The following table summarizes the components of stock-based compensation expense included in the Company’s statements of operations for the years indicated:

 

    For the Years Ended
December 31,
 
    2025     2024  
Research and development   $ 678,180     $ 212,168  
General and administrative     675,309       57,501  
Total   $ 1,353,489     $ 269,669  
Schedule of Fair Value of Stock Options Granted/Modified  

The Company determined the fair value of stock options granted/modified based upon the following assumptions.

 

    For the Years Ended
December 31,
 
    2025     2024  
Stock price   $ 23.10     $ 21.30  
Exercise price   $ 23.10     $ 21.30  
Dividend yield     0 %     0 %
Expected volatility     108.8 %     122.3 – 122.4 %
Risk-Free interest rate     3.87 %     4.29 %
Expected life (in years)     5.00       6.11 – 6.25  
Schedule of Stock Options Outstanding and Exercisable  

The following table presents information related to stock options outstanding and exercisable at December 31, 2025:

 

Options Outstanding     Options Exercisable  
Exercise Price     Outstanding
Number of
Options
    Weighted Average
Remaining Life
In Years
    Exercisable
Number of
Options
 
$ 21.30       46,577       7.37       27,578  
  23.10       62,840       9.50       62,840  
  27.80       5,745       5.39       5,745  
  29.00       10,136       3.44       10,136  
  59.20       1,690       1.09       1,690  
          126,988       8.04       107,989  

 

The following table presents information related to stock options outstanding and exercisable at December 31, 2024:

 

Options Outstanding     Options Exercisable  
Exercise Price     Outstanding
Number of
Options
    Weighted Average
Remaining Life
In Years
    Exercisable
Number of
Options
 
$ 21.30       51,710       8.27       18,531  
  27.80       7,435       6.33       5,576  
  29.00       10,136       4.44       10,136  
  59.20       1,690       2.09       1,690  
          70,971       6.60       35,933  
Schedule of Warrant Activities for Purchase of Common Stock  

The following is a summary of warrant activities for the purchase of Common Stock for the years ended December 31, 2025 and 2024:

 

    Number of
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life In
Years
 
Outstanding, January 1, 2024     33,455     $ 48.42       4.60  
Granted                      
Exercised                      
Forfeited                      
Outstanding December 31, 2024     33,455     $ 48.42       3.60  
Granted                      
Exercised                      
Forfeited     (6,758 )     59.20        
Outstanding December 31, 2025     26,697     $ 45.68       3.36  
Exercisable, December 31, 2024     33,455     $ 48.42       3.60  
Exercisable, December 31, 2025     26,697     $ 45.68       3.36  
Schedule of Information Related to Warrants to Purchase Common Stock Outstanding and Exercisable  

The following table presents information related to warrants to purchase Common Stock outstanding and exercisable at December 31, 2025:

 

Warrants Outstanding     Warrants Exercisable  
Exercise Price     Outstanding
Number of
Warrants
    Weighted Average
Remaining Life
In Years
    Exercisable
Number of
Warrants
 
$ 21.30       2,535       6.51       2,535  
  23.70       845       4.53       845  
  27.80       4,224       5.50       4,224  
  29.00       3,379       3.00       3,379  
  59.20       15,714       2.29       15,714  
          26,697       3.36       26,697  

 

The following table presents information related to warrants to purchase Common Stock outstanding and exercisable at December 31, 2024:

 

Warrants Outstanding     Warrants Exercisable  
Exercise Price     Outstanding
Number of
Warrants
    Weighted Average
Remaining Life
In Years
    Exercisable
Number of
Warrants
 
$ 21.30       2,535       7.51       2,535  
  23.70       845       5.52       845  
  27.80       4,224       6.50       4,224  
  29.00       3,379       4.00       3,379  
  59.20       22,472       2.48       22,472  
          33,455       3.60       33,455  
Schedule of Stock Option Activities  

The following is a summary of stock option activities for the years ended December 31, 2025 and 2024:

 

    Number of
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Grant Date
Fair Value
    Weighted
Average
Remaining
Life In
Years
    Intrinsic
Value
 
Outstanding, January 1, 2024     52,796     $ 24.92     $ 19.03       7.96     $  
Granted     18,788       21.30       18.91       10.00          
Exercised                                      
Forfeited     (613 )     21.30       18.85       8.83          
Outstanding, December 31, 2024     70,971     $ 23.98     $ 19.00       7.53     $  
Granted     62,840       23.10       18.40       10.00          
Exercised                                      
Forfeited     (6,823 )     22.91       19.58       7.43          
Outstanding, December 31, 2025     126,988     $ 23.60     $ 18.67       7.98     $  
Exercisable, December 31, 2024     35,933     $ 26.26     $ 19.32       6.60     $  
Exercisable, December 31, 2025     107,989     $ 24.01     $ 18.68       8.04     $